Humana

Based in KY

🤖

AI Overview

With $2.3M in lobbying spend across 29 quarterly filings, Humana is a significant lobbying presence. They deploy 31 individual lobbyists

$2.3M
Total Lobbying Spend
29
Quarterly Filings
1
Lobbying Firms Used
31
Individual Lobbyists

Spending by Year

YearLobbying Spend
2018$320K
2019$240K
2020$320K
2021$240K
2022$320K
2023$320K
2024$240K
2025$320K

Lobbying Firms

MEHLMAN CONSULTING, INC.

What They Lobby For

  • Implementation of PL 115-97 (H.R. 1/tax reform). Health Insurance Tax.
  • S. 637 - Creating Transparency to have Drug Rebates Unlocked (C-THRU). S. 870 - Creating High Quality Results and Outcomes Necessary to Improve Chronic Care Act (CHRONIC Act) Medicare Advantage Policy and Reimbursement. Medicare Part D issues. Medicaid and Dual Eligible issues. Pharmacy Reimbursement issues. Medicare Access and CHIP Reauthorization Act Implementation. Senate Finance Chronic Care Working Group issues. Opioid issues. Medicare extenders. Special Needs Plans Reauthorization H.R. 1625 - Consolidated Appropriations Act of 2018. H.R. 1892 - Bipartisan Budget Act of 2018.
  • Tricare Contracts and Implementation issues. H.R. 2810 and S. 1510 - FY 2018 National Defense Authorization Act implementation.
  • H.R. 246 - Jobs and Premium Protection Act. ACA Implementation, Medicare Advantage, Prescription Drugs. S. 1859 - Healthcare Tax Relief Act. S. 1978 - Small Business and Family Health Tax Relief Act of 2017. H.R. 4620 - Protecting Families and Small Businesses Act of 2017. H.R. 1892 - Bipartisan Budget Act of 2018.
  • Implementation of PL 115-97 (H.R. 1/tax reform). Health Insurance Tax. HSA Tax Treatment.
  • S. 637 - Creating Transparency to have Drug Rebates Unlocked (C-THRU). Medicare Advantage Policy and Reimbursement. Medicare Part D issues. Medicaid and Dual Eligible issues. Pharmacy Reimbursement issues. Medicare Access and CHIP Reauthorization Act Implementation. H.R. 6 - Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act or the SUPPORT for Patients and Communities Act. Request for Information 0991-ZA49, HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
  • H.R. 246 - Jobs and Premium Protection Act. ACA Implementation, Medicare Advantage, Prescription Drugs. S. 1859 - Healthcare Tax Relief Act. S. 1978 - Small Business and Family Health Tax Relief Act of 2017. H.R. 4620 - Protecting Families and Small Businesses Act of 2017. Request for Information 0991-ZA49, HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
  • Tricare Contracts and Implementation issues. H.R. 2810 and S. 1510 - FY 2018 National Defense Authorization Act implementation. H.R. 5515/S. 2987 - FY 2019 National Defense Authorization Act.
  • S. 637 - Creating Transparency to have Drug Rebates Unlocked (C-THRU). Medicare Advantage Policy and Reimbursement. Medicare Part D issues. Medicaid and Dual Eligible issues. Pharmacy Reimbursement issues. Medicare Access and CHIP Reauthorization Act Implementation. H.R. 6 - SUPPORT for Patients and Communities Act. S. 3120 - HEAL Act of 2018. Request for Information 0991-ZA49, HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
  • H.R. 246 - Jobs and Premium Protection Act. ACA Implementation, Medicare Advantage, Prescription Drugs. S. 1859 - Healthcare Tax Relief Act. S. 1978 - Small Business and Family Health Tax Relief Act of 2017. H.R. 4620 - Protecting Families and Small Businesses Act of 2017. Request for Information 0991-ZA49, HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. H.R. 6 - SUPPORT for Patients and Communities Act. S. 3120 - HEAL Act of 2018. S. 2554 - Patient Right to Know Drug Prices Act. H.R. 878; H.R. 2368/S. 204 - Right-to-Try Legislation.

Related Investigations

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.